About
9.10AUD-0.12 -1.30%
Closed • Updated at 17:23 GMT+00:00Market Cap$332.11M
P/E Ratio14.12
Volume115.8K
Beta0.38
RSI45.02
Gross Margin63.71%
Clinuvel Pharmaceuticals Limited — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 28 2026
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
Apr 27 2026
FDA relaxes SCENESSE postmarketing requirement
Apr 24 2026
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study
Apr 24 2026
Final EMA scientific advice for pivotal Phase III vitiligo
Mar 27 2026
CLINUVEL's global programs showcased at AAD
Translate